Hepatitis A Virus (HAV) Antibody, Total With Reflex to IgM
Also known as: Anti-HAV
Use
This test is used to aid in the diagnosis of active Hepatitis A (HAV) infection and differentiate between active and previous infection/vaccination.
Special Instructions
Not provided.
Limitations
This assay has not been FDA cleared or approved for screening blood or plasma donors. Performance characteristics have not been determined for immunocompromised patients, cord blood, patients less than 2 years of age, or cadaveric specimens. The assay does not differentiate between IgG and IgM antibodies.
Methodology
Immunoassay (Immunochemiluminometric assay (ICMA))
Biomarkers
Hepatitis A Virus (HAV) Antibody, Total
AnalyteHepatitis A Virus (HAV) IgM Antibody
Analyte
LOINC Codes
- 13951-9 - HAV Ab Ser Ql IA
- 13951-9 - HAV Ab Ser Ql IA
- 13950-1 - HAV IgM SerPl Ql IA
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.8 mL
Container
Gel-barrier tube, red-top tube or serum transfer tube
Collection Instructions
If tube other than a gel-barrier tube is used, transfer separated serum to a screw-cap polypropylene transport tube. Do not freeze gel-barrier tube (pour off serum first).
Storage Instructions
Room temperature
Causes for Rejection
Heat-inactivated specimens; cord blood; cadaveric specimens; or body fluid other than serum or EDTA plasma; gross hemolysis; excessive lipemia; improper labeling
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant